The Company announces that its Annual General Meeting will be held on Thursday 26 June 2025, at the offices of Travers Smith LLP, 10 Snow Hill, London EC1A 2AL, England at 4.00 pm (BST).

RESOLVED that Deloitte & Touche and Deloitte & Touche LLP be and are hereby appointed as the independent external auditors of the Company until the next Annual General Meeting and that the ...

Approval of a gross dividend of € 1.90 per share - Approval of the proposed appointments and reappointments of Directors On Wednesday 14 May 2025, Bekaert’s Annual General Meeting of Shareholders took ...

The RFU’s 2025 Annual General Meeting (AGM) will be held at 14:30 on Saturday 28 June 2025 in the Sir Bobby Robson Lobby, at St George's Park, Staffordshire. The meeting will be held on a hybrid basis ...

to approve the principles of remuneration of the Management Board of Arco Vara AS as set out in the materials of the general meeting and made available to shareholders. Extension of the Supervisory ...

The Chartered Institute of Bankers of Nigeria has announced that its 2025 Annual General Meeting will take place on May 17. In a statement on Sunday, it said this year’s AGM will be a hybrid ...

Today, on 7 May 2025, the annual general meeting was held in Alligator Bioscience AB. A summary of the adopted resolutions follows below. Resolution on adoption of accounts and distribution of the ...

MALMÖ, SE / ACCESS Newswire / May 7, 2025 / Ascelia Pharma (STO:ACE) - Today, on 7 May 2025, an annual general meeting was held in Ascelia Pharma AB. A summary of the adopted resolutions follows below ...

RAPALA VMC CORPORATION, Notice to general meeting, April 10, 2025 at 3:31 p.m. EET The shareholders of Rapala VMC Corporation (“Rapala VMC” or the “Company”) are invited to the Annual General Meeting, ...

Proxy representatives shall produce a dated proxy document or otherwise in a reliable manner demonstrate their right to represent the shareholder at the Annual General Meeting. Proxy document template ...

Doha, Qatar: Ooredoo held its Annual General Meeting today, where Shareholders discussed and approved the Company’s Corporate Governance Report and financial statements, following confirmation of full ...

Annual Meeting, taking place April 5-9, 2025, in San Diego, California. Ulviprubart is a first-in-class monoclonal antibody targeting killer cell lectin like receptor G1 (KLRG1), currently being ...